<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2013-04-29 14:47:48Myeloproliferative disease Chromosome 5q deletion syndrome Myelodysplastic syndrome Medicine Sideroblastic anemia Anemia |
Add to Reading List |
AA&MDSIF_ResourceCard_11x8.5 | Contact: Robert J. Hugin Senior VP and CFO Celgene Corporation[removed]DocID: NWvT - View Document |
| Contact: Robert J. Hugin Senior VP and CFO Celgene Corporation[removed]DocID: NVKH - View Document |
| AA&MDSIF_ResourceCard_11x8.5DocID: CUcF - View Document |
| fall 2008: volume 13, issue 2 newsletter of the myelodysplastic syndromes foundation From the Guest Editor’s Desk The Molecular Basis of the 5q- syndromeDocID: BZYZ - View Document |
| Microsoft Word - Final Determination _Lenalidomide in MDS 2013 update_FINAL.docxDocID: uidU - View Document |